November 14, 2026

Strategic Investment

You may have missed

Safi Biotherapeutics, a US biotechnology company developing stem-cell-derived manufactured red blood cells for civilian and military transfusion needs.

Safi Biotherapeutics Receives $4.7 Million Non-Dilutive Award Extension Through MTEC.

November 3, 2026 0
Novel Financial Holdings corporate branding for its equity investment announcement involving Crestview Partners.

Novel Financial Holdings Secures Investment From Crestview Partners to Expand Insurance Platform.

November 3, 2026 0
Newleos Therapeutics company logo representing the Boston-based biotechnology company awarded an NIH grant of up to $15.5 million for NTX-2001 development.

Newleos Therapeutics Secures Up to $15.5 Million NIH Grant for Cocaine Use Disorder Drug Development.

November 3, 2026 0
Corridian, a US defense technology startup developing ultra-large autonomous underwater vehicles for maritime logistics and defense applications.

Corridian Raises $38 Million in Seed Funding Led by Point72 Ventures.

November 3, 2026 0
Hoxton Wealth and Aspirity Partners logos representing the announced $135 million strategic minority investment.

Hoxton Wealth Secures $135 Million Minority Investment Commitment From Aspirity Partners.

November 3, 2026 0
Vitroscope, a Norwegian biotechnology company developing live-tissue research platforms for laboratory and drug discovery applications.

Vitroscope Raises $7 Million in Seed and Non-Dilutive Funding Led by Cerberus Ventures and YZR Capital.

November 3, 2026 0

Get the latest startup funding news in your inbox.

We don’t spam! Read our privacy policy for more info.